Salesforce Earnings Can Put AI Fears to Bed, Give Stock a Lift

Salesforce has fallen 32% this year and trades at just 13x estimated earnings, well below its 10-year average of 45, as investors worry AI could weaken demand and pricing power. Yet fundamentals remain solid: revenue is expected to grow 11% in fiscal 2027 versus 9.6% in fiscal 2026, and 47 of 62 analysts still rate it a buy with a $253 average target implying 39% upside. The article frames the earnings report as a potential catalyst for the stock to recover if management can ease AI disruption fears.

Analysis

CRM is not trading like a cyclical software recovery story; it is trading like a durability bet with a broken multiple. That matters because the stock’s setup is now dominated by sentiment re-rating rather than near-term operating inflection: if management simply confirms retention and free-cash-flow resilience, the path of least resistance is a sharp multiple expansion from a depressed base. The asymmetric part is that a modest beat is likely not enough — investors need evidence that AI is augmenting seat expansion or pricing, not just preserving churn.

The second-order winner is not necessarily the platform vendors that get the headlines, but the adjacent software names with clearer AI monetization or more modular workflows, where investors can underwrite faster conversion to revenue. Conversely, the broker-note downgrade on CRM is a reminder that if AI cannibalization is real, it will show up first in budget allocation: customers may slow net-new deployments while increasing spend on copilots, workflow automation, and inference-heavy tools. That creates a mix shift risk for incumbents that can look stable on revenue but lose incremental growth leverage over the next 2-4 quarters.

The contrarian view is that the market may be overpricing the probability of wholesale CRM displacement. Enterprise data gravity, compliance workflows, and implementation inertia make replacement a multi-year process, so the near-term bear case likely depends more on buyer caution than product obsolescence. If guidance merely suggests stable double-digit growth, the stock can re-rate quickly because the current multiple implies a far more severe deterioration than fundamentals justify.

For the broader tape, the strong software earnings season improves the odds that this was a valuation washout rather than a regime change. That should support a selective bid in quality software, but the market will still punish any company where AI is not clearly translating into either higher spend per customer or lower cost of service. CRM is the key test case because it sits at the intersection of defensiveness and AI disruption fears.

Key Decisions for Investors

• Go long CRM into the print or on any post-earnings gap down if guidance stays above consensus revenue growth; target a 15-25% re-rating over 1-3 months, with downside limited by already-depressed multiples.
• Use a CRM/NOW pair: long CRM, short NOW for 4-8 weeks if CRM confirms durable retention and NOW implies richer AI monetization; CRM offers more upside from sentiment normalization while NOW carries higher execution expectations.
• Buy CRM call spreads 1-3 months out, structured for a 20-30% upside move; the option market should capture the asymmetry if the stock re-rates on confirmation rather than acceleration.
• Fade the most AI-disruption-sensitive niche software names versus CRM on any sector rally; the first leg of the recovery should favor entrenched platforms with proprietary data and switching costs.
• If CRM misses on billings or raises AI cannibalization concerns, short the bounce rather than the initial reaction — the next leg lower could be another 10-15% as multiple compression resumes.